Clovis Oncology Inc. (CLVS) Dropped -5.22% or -1.64 To Price $29.81 On Thursday


Clovis Oncology Inc. (CLVS) dropped -5.22% or -1.64 to $29.81. It is near 687024 shares traded, which is 47.49% compare to the average total volume 1.45 million. The market cap of CLVS is $1.57 billion. The year to date change is -57.6%. The 52 week price range is from $26.21 to $81.88. Price of CLVS have changed 12.64% during last week. It have changed -2.42% over last month, -32.54% over last 3 months, -40.96% over last 6 months and -61.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 33.00. It is 10.70% above current price. The 200-day Moving Averages for CLVS is 47.26. It is 58.54% above current price. The 52-week High is 81.88. It is 174.67% from the current price. The 52-week Low is 26.21. It is -12.08% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLVS is 10.01 on 2018-09-28. Short % to float is 17.93%. There are some statistics of CLVS. It is has market cap $1.57 billion. The share outstanding is 52.65 million. The average volume is 1.45 million. The revenue is 16.81M. The gross profit is 13.41M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -87.79%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -31.73%.


Tags:

Share this post